Abstract:Introduction: Rotavirus vaccine evaluations have noted small differences in vaccine effectiveness (VE) against rotavirus genotypes, defined by the two outer capsid proteins (VP7 or G-type and VP4 or P-type). However, the genomic landscape of group A rotavirus (RVA) and the impact of the remaining nine genome segments (i.e., the "backbone") on VE are not fully understood. We incorporated whole genome sequence (WGS) data to characterize viruses responsible for rotavirus-associated gastroenteritis (RVGE) between vaccinated and unvaccinated individuals in the United States (U.S.). Methods: We analyzed 254 RVGE cases with WGS data from seven U.S. New Vaccine Surveillance Network sites during 2012-2016. Using a "sieve analysis" framework, we evaluated the variability in vaccine protection based on genetic distance (GD) defined at WGS-level as the percent nucleotide difference between each case strain and the vaccine strain(s). Strain-specific VE estimates were calculated using the test-negative design, controlling for potential cofounders. Separate analyses were performed for the monovalent Rotarix® vaccine (RV1, GlaxoSmithKline) and the pentavalent RotaTeq® vaccine (RV5, Merck & Co.). We also examined the site-specific genetic diversity of circulating RVA strains in relation to vaccine coverage. Results: RV1-vaccinated cases were more likely to be infected with strains with greater than 9.6% GD from the RV1 vaccine strain (unadjusted OR = 3.03, 95% confidence interval (CI): 1.15, 8.03). Strains with a Genogroup 1 (Wa-like) backbone represented the majority (99%) of cases below the threshold, whereas more distant strains had genetic backbones that resembled the Genogroup 2 (DS-1-like) and reassortant strains. The RV1 vaccine showed evidence of substantially better protection against strains with lower GD to the RV1 strain (VE = 80%, 95% CI: 68%, 89%) compared to more distant strains (VE = 51%, 95% CI: = -29%, 82%). RV5 demonstrated a similar but less pronounced pattern of better protection against strains with a lower minimum GD to the vaccine strains. Sites with higher RV1 usage showed a shift in strain distribution towards greater GD from the RV1 strain, with a similar trend observed for RV5. Conclusion: Incorporating the complete genomic structure of RVA reveals that vaccine protection correlates with the diversity of non-outer capsid proteins. Our WGS-based analysis more clearly differentiated vaccine protection than analyses based on VP7 and VP4 alone. With more RVA vaccines in the pipeline, understanding the contribution of all gene segments to immune protection will be key to ensuring the long-term success of RVA vaccination programs.

Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens

The molecular epidemiology of human group A rotavirus infections in children in Hangzhou in 2017

Histo-blood group antigens as divergent factors of groups A and C rotaviruses circulating in humans and different animal species

Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion

[Analysis of VP7 Serotype of Rotavirus in Infantile Diarrhea in Hangzhou Area from 2001 to 2003].

Human group C rotavirus VP8*s recognize type A histo-blood group antigens as ligands.

Structural and functional characterization of bovine G1P[5] rotavirus VP8* protein

Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains

Human group A rotavirus P[25] VP8* specifically binds to A-type histo-blood group antigen

Longitudinal Surveillance of Porcine Rotavirus B Strains from the United States and Canada and In Silico Identification of Antigenically Important Sites

Genetic Susceptibility to Rotavirus Infection in Chinese Children: a Population-Based Case–control Study

Genotype distribution and evolutionary analysis of rotavirus associated with acute diarrhea outpatients in Hubei, China, 2013–2016

Human rotavirus strains circulating among children in the capital of China (2018-2022)_ predominance of G9P[8] and emergence ofG8P[8]

The Functional Characterization of Bat and Human P[3] Rotavirus VP8*s

Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains

Global Infection Rate of Rotavirus C during 1980-2022 and Analysis of Critical Factors in the Host Range Restriction of Virus VP4

Estimation of Rotavirus Vaccine Effectiveness Based on Whole Genome Sequences

Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in southwest China

The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa

Evolutionary changes between pre- and post-vaccine South African group A G2P[4] rotavirus strains, 2003-2017

Group A Rotavirus NSP4 is Under Negative Selective Pressure